ATE353642T1 - Verwendung von hypoestoxiden als antiparasitäre mittel - Google Patents

Verwendung von hypoestoxiden als antiparasitäre mittel

Info

Publication number
ATE353642T1
ATE353642T1 AT00947101T AT00947101T ATE353642T1 AT E353642 T1 ATE353642 T1 AT E353642T1 AT 00947101 T AT00947101 T AT 00947101T AT 00947101 T AT00947101 T AT 00947101T AT E353642 T1 ATE353642 T1 AT E353642T1
Authority
AT
Austria
Prior art keywords
hypoestoxides
antiparasitive
agents
insultors
theeof
Prior art date
Application number
AT00947101T
Other languages
English (en)
Inventor
Emmanuel A Ojo-Amaize
Joseph I Okogun
Emeka J Nchekwube
Original Assignee
Paraquest Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paraquest Inc filed Critical Paraquest Inc
Application granted granted Critical
Publication of ATE353642T1 publication Critical patent/ATE353642T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
AT00947101T 1999-07-06 2000-07-06 Verwendung von hypoestoxiden als antiparasitäre mittel ATE353642T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/347,900 US6242484B1 (en) 1999-07-06 1999-07-06 Hypoestoxides, derivatives and agonists thereof for use of antiparasitic agents

Publications (1)

Publication Number Publication Date
ATE353642T1 true ATE353642T1 (de) 2007-03-15

Family

ID=23365772

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00947101T ATE353642T1 (de) 1999-07-06 2000-07-06 Verwendung von hypoestoxiden als antiparasitäre mittel

Country Status (6)

Country Link
US (1) US6242484B1 (de)
EP (1) EP1225892B1 (de)
AT (1) ATE353642T1 (de)
AU (1) AU6076500A (de)
DE (1) DE60033416T2 (de)
WO (1) WO2001001975A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1143646A1 (de) 2000-04-05 2001-10-10 Telefonaktiebolaget Lm Ericsson Optisches Kommunikationssystem mit zwei parallelen Übertragungswegen
WO2003022266A1 (en) * 2001-08-24 2003-03-20 Paraquest, Inc. Hypoestoxides, derivatives and agonists thereof for use as inhibitors of angiongenesis
ATE327749T1 (de) * 2002-10-28 2006-06-15 Paraquest Inc Hypoestoxide, derivate und agonisten davon zur verwendung bei der behandlung und prophylaxe von hyperlipidämie
US7125854B2 (en) * 2003-01-07 2006-10-24 Kemin Pharma B.V.B.A. Bicyclic carbohydrates as antiprotozoal bioactive for the treatment of infections caused by parasites
US7229979B2 (en) * 2003-06-23 2007-06-12 Immune Modulation, Inc. Hypoestoxides, derivatives and agonists thereof for use as stent-coating agents
US20050112071A1 (en) * 2003-10-23 2005-05-26 Paraquest, Inc. Hypoestoxides, derivatives, agonists and crude extracts thereof for use in cosmetic compositions
US20060094695A1 (en) * 2004-11-02 2006-05-04 Paraquest, Inc. Hypoestoxides, derivatives and agonists thereof for use in the prophylaxis and treatment of obesity
US8124654B2 (en) * 2008-11-11 2012-02-28 Immune Modulation, Inc. Derivatives of hypoestoxide and related compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994328A (en) * 1998-01-14 1999-11-30 Immune Modulation, Inc. Hypoestoxides, derivatives and agonists thereof for use as anticancer agents
US5801193A (en) * 1997-04-15 1998-09-01 Immune Modulation, Inc. Compositions and methods for immunosuppressing
US6001871A (en) * 1998-01-15 1999-12-14 Immune Modulation, Inc. Hypoestoxides, derivatives and agonists thereof for use as antiviral agents

Also Published As

Publication number Publication date
US6242484B1 (en) 2001-06-05
WO2001001975A3 (en) 2002-05-23
AU6076500A (en) 2001-01-22
DE60033416T2 (de) 2007-11-29
WO2001001975A2 (en) 2001-01-11
DE60033416D1 (de) 2007-03-29
EP1225892B1 (de) 2007-02-14
EP1225892A2 (de) 2002-07-31

Similar Documents

Publication Publication Date Title
BRPI0317696B8 (pt) composição para branqueamento
TR200101793T2 (tr) CCR5 modülatörleri olarak azabisikloalkanlar
MY135732A (en) 5,6-trimethylenepyrimidin - 4 - one compounds
DE60035032D1 (de) Verwendung von pioglitazone zur verbesserung der ketose und der azidose
EA200100731A1 (ru) Фенилфенантридины с ингибирующей фдэ-4 активностью
DE50211045D1 (de) Medizinische aerosolformulierungen
TR200200883T2 (tr) 2-ikameli 1,1-bifenil-2-karbonamidler, imalat yöntemleri, ilaç olarak kullanılmaları
ATE260650T1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
AU2001266575A1 (en) Chemical compounds
BRPI0414215A (pt) tienopirazóis
AU2002317501A1 (en) Antiobestic and/or antidiabetic agent containing cyanidin 3-glucoside as active ingredient
AU2003280918A1 (en) Rabbit skin comprising biological active substance and its use
BR0213994A (pt) Derivados heterocìclicos de glicinamida e seus usos médicos
ATE289749T1 (de) Verwendung von polysiloxanen mit quartären aminogruppen als formulierungshilfsmittel und mittel enthaltend dieselben
ATE314084T1 (de) Kahalalid f formulierung
SE0102147D0 (sv) New methods
PT1147103E (pt) Fenantridina-n-oxidos com actividade inibitoria de pde-iv
ATE353642T1 (de) Verwendung von hypoestoxiden als antiparasitäre mittel
PT1147088E (pt) 6-arilfenantridinas com actividade inibitoria da pde-iv
NO2019032I1 (no) Treosulfan
BR0309878A (pt) Heterotriciclil-6-alquilideno-penemas como inibidores de beta-lactamase
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
AU2001238332A1 (en) Method of sterilizing articles
DE60122559D1 (de) Indolderivate als pde5-inhibitoren
ATE416782T1 (de) Medizinische verwendung von il-174 agonisten und antagonisten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties